Free Trial

Prospera Private Wealth LLC Boosts Stock Position in The Procter & Gamble Company (NYSE:PG)

Procter & Gamble logo with Consumer Staples background

Prospera Private Wealth LLC raised its holdings in The Procter & Gamble Company (NYSE:PG - Free Report) by 240.7% in the 3rd quarter, according to the company in its most recent filing with the SEC. The firm owned 10,589 shares of the company's stock after acquiring an additional 7,481 shares during the quarter. Prospera Private Wealth LLC's holdings in Procter & Gamble were worth $1,834,000 as of its most recent SEC filing.

Several other large investors have also recently modified their holdings of PG. Itau Unibanco Holding S.A. bought a new position in Procter & Gamble during the 2nd quarter worth approximately $28,000. Fairway Wealth LLC acquired a new stake in shares of Procter & Gamble during the second quarter worth $29,000. POM Investment Strategies LLC acquired a new position in Procter & Gamble in the second quarter valued at $34,000. Quest Partners LLC bought a new stake in Procter & Gamble during the second quarter valued at $36,000. Finally, Fairfield Financial Advisors LTD acquired a new stake in Procter & Gamble during the 2nd quarter worth about $44,000. Institutional investors own 65.77% of the company's stock.

Procter & Gamble Stock Performance

Shares of Procter & Gamble stock traded down $0.25 during trading hours on Wednesday, hitting $170.51. 2,415,660 shares of the company's stock traded hands, compared to its average volume of 6,653,525. The stock has a market capitalization of $401.56 billion, a price-to-earnings ratio of 29.37, a PEG ratio of 3.67 and a beta of 0.42. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.75 and a quick ratio of 0.55. The Procter & Gamble Company has a 12-month low of $142.50 and a 12-month high of $177.94. The company has a fifty day simple moving average of $170.07 and a 200-day simple moving average of $168.49.

Procter & Gamble (NYSE:PG - Get Free Report) last issued its quarterly earnings results on Friday, October 18th. The company reported $1.93 EPS for the quarter, beating analysts' consensus estimates of $1.90 by $0.03. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The firm had revenue of $21.74 billion for the quarter, compared to analysts' expectations of $21.99 billion. During the same quarter in the prior year, the firm earned $1.83 EPS. The business's revenue for the quarter was down .6% compared to the same quarter last year. Equities research analysts anticipate that The Procter & Gamble Company will post 6.94 EPS for the current fiscal year.

Procter & Gamble Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Friday, October 18th were paid a $1.0065 dividend. The ex-dividend date was Friday, October 18th. This represents a $4.03 annualized dividend and a yield of 2.36%. Procter & Gamble's dividend payout ratio is currently 69.48%.

Wall Street Analysts Forecast Growth

Several equities research analysts recently commented on the company. DA Davidson restated a "neutral" rating and set a $160.00 target price on shares of Procter & Gamble in a research report on Wednesday. TD Cowen initiated coverage on shares of Procter & Gamble in a research report on Tuesday, July 23rd. They set a "buy" rating and a $189.00 price objective for the company. Wolfe Research raised shares of Procter & Gamble to a "strong-buy" rating in a research note on Friday, August 23rd. Evercore ISI lifted their price target on shares of Procter & Gamble from $180.00 to $183.00 and gave the company an "outperform" rating in a research note on Monday, October 21st. Finally, Morgan Stanley raised their target price on Procter & Gamble from $174.00 to $191.00 and gave the company an "overweight" rating in a research note on Monday, October 21st. Nine investment analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have assigned a strong buy rating to the company's stock. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus target price of $177.00.

View Our Latest Analysis on PG

Insider Transactions at Procter & Gamble

In other Procter & Gamble news, CFO Andre Schulten sold 13,041 shares of Procter & Gamble stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $170.00, for a total transaction of $2,216,970.00. Following the completion of the sale, the chief financial officer now directly owns 37,208 shares in the company, valued at $6,325,360. The trade was a 25.95 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Susan Street Whaley sold 634 shares of the stock in a transaction on Wednesday, October 2nd. The shares were sold at an average price of $171.65, for a total value of $108,826.10. Following the completion of the transaction, the insider now directly owns 19,341 shares in the company, valued at approximately $3,319,882.65. This represents a 3.17 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 270,727 shares of company stock valued at $46,014,037. 0.18% of the stock is currently owned by corporate insiders.

Procter & Gamble Company Profile

(Free Report)

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.

Read More

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Should you invest $1,000 in Procter & Gamble right now?

Before you consider Procter & Gamble, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.

While Procter & Gamble currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

How Abacus Life is Transforming Life Insurance into Assets | MarketBeat CEO Series
NVIDIA Earnings: Can Blackwell Propel the Stock to $200+ in 2025?
These Top Stocks in 2024 Will Continue to be Big Winners in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines